Market Tracker

09/30 5:50am ET

Exelixis Inc (NASDAQ:EXEL)

12.28
Delayed Data
As of Sep 29
 -1.07 / -8.01%
Today’s Change
3.55
Today|||52-Week Range
15.58
+117.73%
Year-to-Date
Why Exelixis, Inc. Continued Its Downfall Today
Sep 29 / MotleyFool.com - Paid Partner Content
'Mad Money' Lightning Round: Don't Sell Scripps
Sep 23 / TheStreet.com - Paid Partner Content
Why Exelixis, Inc. Got Hammered Today
Sep 28 / MotleyFool.com - Paid Partner Content
3 Reasons Momentum Stock Investors Will Love Exelixis (EXEL)
Sep 20 / Zacks.com - Paid Partner Content
Exelixis (EXEL) Stock Plummets on Cancer Drug Trial Results, Leerink: Selloff Overdon...
Sep 28 / TheStreet.com - Paid Partner Content
These 3 Stocks Have Doubled Their Investors' Money
Sep 17 / MotleyFool.com - Paid Partner Content
Surging Earnings Estimates Signal Good News for Exelixis (EXEL)
Sep 26 / Zacks.com - Paid Partner Content
Forget Novavax, Buy These 4 Biotech Stocks Instead
Sep 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close13.35
Today’s open12.98
Day’s range11.71 - 13.00
Volume17,038,918
Average volume (3 months)6,473,272
Market cap$3.1B
Dividend yield--
Data as of 09/29/2016

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)+23.25%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+48.03%
P/E ratioNM
Price/Sales31.75
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PRAHPRA Health Sciences ...-0.76-1.36%
INCRINC Research Holding...-0.41-0.92%
PRXLPAREXEL Internationa...-1.82-2.59%
CRLCharles River Labora...-1.01-1.21%
Data as of 09/29/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$37.2M
Annual profit (last year)-$169.7M
Net profit margin-456.63%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts